Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CXCL10 antagonists(C-X-C motif chemokine ligand 10 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Phase 2 | US | 30 Jan 2022 |